Trial · NCT05028582
Outcomes20
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Achievement of Scalp Investigator Global Assessment (S-IGA) Success at Week 8 | Week 8 | All randomized participants are included, with multiple imputation of missing data. | percentage of participants | NUMBER |
| PRIMARY | Achievement of Body Investigator Global Assessment (B-IGA) Success at Week 8 | Week 8 | All randomized participants are included, with multiple imputation of missing data. | percentage of participants | NUMBER |
| SECONDARY | Achievement of Scalp Itch-Numeric Rating Score (SI-NRS ) Success at Week 2 | Week 2 | All randomized participants with weekly average baseline SI-NRS ≥4 are included. | percentage of participants | NUMBER |
| SECONDARY | Achievement of SI-NRS Success at Week 4 | Week 4 | All randomized participants with weekly average baseline SI-NRS ≥4 are included. | percentage of participants | NUMBER |
| SECONDARY | Achievement of SI-NRS Success at Week 8 | Week 8 | All randomized participants with weekly average baseline SI-NRS ≥4 are included. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in SI-NRS Score at Day 1 | Day 1 | All randomized participants with average, weekly SI-NRS ≥4 at baseline are included. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in SI-NRS Score at Day 3 | Day 3 | All randomized participants are included. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in SI-NRS Score at Week 1 | Week 1 | All randomized participants are included. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Achievement of WI-NRS (Worst Itch-Numeric Rating Score) Success at Week 8 | Week 8 | All randomized participants with average, weekly WI-NRS ≥4 at baseline are included. | percentage of participants | NUMBER |
| SECONDARY | Achievement of a 75% Reduction From Baseline in Psoriasis Area and Severity Index (PASI-75) | Week 8 | All randomized participants are included, with multitple imputation of missing data. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in Psoriasis Symptoms Diary (PSD) Aggregate Score of Itching, Pain, and Scaling (Questions 1, 9, and 11) | Week 8 | All randomized participants ≥18 years of age are included. | score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Participants Achieving PSD Itching (Question 1) Score of 0 at Week 8 | Week 8 | All randomized participants ≥18 years of age are included. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Achieving PSD Pain (Question 9) Score of 0 at Week 8 | Week 8 | All randomized participants ≥18 years of age are included. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Achieving PSD Scaling (Question 11) Score of 0 at Week 8 | Week 8 | All randomized participants ≥18 years of age are included. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Achieving PSD Total Score of 0 at Week 8 | Week 8 | All randomized participants ≥18 years of age are included. | percentage of participants | NUMBER |
| SECONDARY | Achievement of a 75% Reduction From Baseline in Psoriasis Scalp Severity Index (PSSI) Score (PSSI-75) | Week 8 | All randomized participants are included, with multiple imputation of missing data.. | percentage of participants | NUMBER |
| SECONDARY | Achievement of S-IGA Score of 'Clear' at Week 8 | Week 8 | All randomized participants are included, with multiple imputation of missing data. | percentage of participants | NUMBER |
| SECONDARY | Achievement of S-IGA Success at Week 2 | Week 2 | All randomized participants are included, with multiple imputation of missing data. | percentage of participants | NUMBER |
| SECONDARY | Achievement of S-IGA Success at Week 4 | Week 4 | All randomized participants are included, with multiple imputation of missing data. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in PASI Score at Week 2 | Week 2 | All randomized participants are included, with multiple imputation of missing data. | score on a scale | LEAST_SQUARES_MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05028582/outcomes